4-bromo-a-23187 has been researched along with reserpine in 1 studies
Studies (4-bromo-a-23187) | Trials (4-bromo-a-23187) | Recent Studies (post-2010) (4-bromo-a-23187) | Studies (reserpine) | Trials (reserpine) | Recent Studies (post-2010) (reserpine) |
---|---|---|---|---|---|
63 | 0 | 5 | 15,546 | 223 | 436 |
Protein | Taxonomy | 4-bromo-a-23187 (IC50) | reserpine (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 8.7875 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.2092 | |
Quinolone resistance protein NorA | Staphylococcus aureus | 8.5429 | |
Mu-type opioid receptor | Homo sapiens (human) | 4.152 | |
Chromaffin granule amine transporter | Homo sapiens (human) | 0.05 | |
Synaptic vesicular amine transporter | Rattus norvegicus (Norway rat) | 0.0034 | |
Synaptic vesicular amine transporter | Homo sapiens (human) | 0.0147 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alter, A; Baram, D; Blickstein, D; Mekori, YA; Radnay, J; Ravid, M; Rozenszajn, LA | 1 |
1 other study(ies) available for 4-bromo-a-23187 and reserpine
Article | Year |
---|---|
Characterization of the interference of T cell activation by reserpine.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Calcimycin; Calcium; CD4 Antigens; CD8 Antigens; Humans; Immunosuppression Therapy; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Phytohemagglutinins; Receptors, Interleukin-2; Reserpine; T-Lymphocytes | 1989 |